US company is attempting to acquire the maker of a new treatment for pancreatic cancer
Merck in talks to buy cancer drugmaker Revolution Medicines for up to $32bn
Recent Posts
- Carson Block sees new dawn for short sellers in AI disruption
- Meta builds AI version of Mark Zuckerberg to interact with staff
- What happens in Sudan will not stay in Sudan
- The risks of Trump’s Strait of Hormuz blockade plan
- UK Treasury to profit from final year of student loan scheme, says analysis
